Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. COVID-19 Vaccines Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid spread of coronavirus resulting in a large number of deaths
5.1.1.2. Government support and grants for COVID-19 vaccines
5.1.1.3. Increasing research and development (R&D) initiatives for vaccines
5.1.2. Restraints
5.1.2.1. Limited supportive infrastructure, skills, and technology in developing areas around the world
5.1.3. Opportunities
5.1.3.1. Growing amalgamation activities to manufacture and distribute the COVID-19 vaccines
5.1.3.2. Rising investments for vaccines
5.1.4. Challenges
5.1.4.1. Side effects associated with the COVID-19 vaccines
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. COVID-19 Vaccines Market, by Product Type
6.1. Introduction
6.2. Monovalent Vaccine
6.3. Multivalent Vaccine

7. COVID-19 Vaccines Market, by End-User
7.1. Introduction
7.2. Academic & Research Centers
7.3. Clinics
7.4. Hospitals
7.5. Vaccination Centers

8. COVID-19 Vaccines Market, by Patient Type
8.1. Introduction
8.2. Adult
8.3. Pediatric
8.4. Senior Citizens

9. Americas COVID-19 Vaccines Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific COVID-19 Vaccines Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa COVID-19 Vaccines Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AIVITA Biomedical Inc.
13.1.2. AstraZeneca PLC
13.1.3. Baseimmune Ltd.
13.1.4. Bharat Biotech International Ltd.
13.1.5. Biological E. Ltd.
13.1.6. CanSino Biologics Inc.
13.1.7. Centivax Inc.
13.1.8. Codagenix Inc.
13.1.9. CureVac SE
13.1.10. Dr. Reddy’s Laboratories Ltd.
13.1.11. Emergex Vaccines Holding Ltd.
13.1.12. Etherna Immunotherapies NV
13.1.13. Gennova Biopharmaceuticals Ltd.
13.1.14. GlaxoSmithKline PLC
13.1.15. HDT Bio, Inc.
13.1.16. Meissa Vaccines, Inc.
13.1.17. Merck & Co., Inc.
13.1.18. Moderna, Inc.
13.1.19. Novavax Inc.
13.1.20. Osivax SAS
13.1.21. Pfizer Inc.
13.1.22. Providence Therapeutics Inc.
13.1.23. SANOFI
13.1.24. Serum Institute of India Pvt. Ltd.
13.1.25. Sinovac Biotech Ltd.
13.1.26. Vaccitech PLC
13.1.27. Zydus Lifesciences Ltd.
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. COVID-19 VACCINES MARKET RESEARCH PROCESS
FIGURE 2. COVID-19 VACCINES MARKET SIZE, 2023 VS 2030
FIGURE 3. COVID-19 VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. COVID-19 VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. COVID-19 VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. COVID-19 VACCINES MARKET DYNAMICS
FIGURE 7. COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 8. COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. COVID-19 VACCINES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. COVID-19 VACCINES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
FIGURE 12. COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. COVID-19 VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. COVID-19 VACCINES MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. COVID-19 VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. COVID-19 VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COVID-19 VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 6. COVID-19 VACCINES MARKET SIZE, BY MONOVALENT VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. COVID-19 VACCINES MARKET SIZE, BY MULTIVALENT VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 9. COVID-19 VACCINES MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. COVID-19 VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. COVID-19 VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. COVID-19 VACCINES MARKET SIZE, BY VACCINATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 14. COVID-19 VACCINES MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. COVID-19 VACCINES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. COVID-19 VACCINES MARKET SIZE, BY SENIOR CITIZENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 27. CANADA COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 28. CANADA COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. CANADA COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 30. MEXICO COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. MEXICO COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 44. CHINA COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. CHINA COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. CHINA COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 47. INDIA COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. INDIA COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. INDIA COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. JAPAN COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. JAPAN COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. THAILAND COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. THAILAND COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. DENMARK COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. DENMARK COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 84. EGYPT COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. EGYPT COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 87. FINLAND COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. FINLAND COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 90. FRANCE COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. FRANCE COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 93. GERMANY COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. GERMANY COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 99. ITALY COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. ITALY COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. ITALY COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 108. NORWAY COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. NORWAY COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 111. POLAND COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. POLAND COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. POLAND COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 114. QATAR COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. QATAR COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. QATAR COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 126. SPAIN COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. SPAIN COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 135. TURKEY COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. TURKEY COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 144. COVID-19 VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. COVID-19 VACCINES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. COVID-19 VACCINES MARKET LICENSE & PRICING